z-logo
Premium
The involvement of the cytoskeleton in regulating IP 3 receptor‐mediated internal Ca 2+ release in human blood platelets.
Author(s) -
Bourguig Lilly Y. W.,
Iida Naoko,
Jin Hengtao
Publication year - 1993
Publication title -
cell biology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.932
H-Index - 77
eISSN - 1095-8355
pISSN - 1065-6995
DOI - 10.1006/cbir.1993.1136
Subject(s) - platelet , cytochalasin b , cytoskeleton , microbiology and biotechnology , receptor , cytochalasin d , chemistry , microfilament , biochemistry , biology , biophysics , in vitro , cell , immunology
In this study we have used saponin to permeabilize platelet membranes in order to test directly the involvement of IP 3 in regulating internal Ca 2+ release, and to measure IP 3 binding to its receptor. Our results indicate that platelet vesicles release Ca 2+ as early as 3 seconds after IP 3 addition. Using [ 3 H]IP 3 , we have found that platelets contain a single class of high affinity IP 3 binding sites with a Kd of ∼0.20 (± 0.01) nM. Immuno‐blotting shows that platelets contain a 260 kDa polypeptide which shares immunological cross reactivity with brain IP 3 receptor. Immunofluorescence staining data indicate that the IP 3 receptor is preferentially located at the periphery of the platelet plasma membrane. Most importantly, both IP 3 binding and IP 3 ‐induced Ca 2+ release activities are significantly inhibited by cytochalasin D (a microfilament inhibitor) and colchicine (a microtubule inhibitor). These findings suggest that the cytoskeleton is involved in the regulation of IP 3 binding and IP 3 receptor‐mediated Ca 2+ release during platelet activation.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom